Fast Five Quiz: How Much Do You Know About Cardiovascular Risk Factors?

Yasmine S. Ali, MD


April 13, 2018

According to the guidelines, the four groups most likely to benefit from statin therapy in addition to lifestyle changes include the following:

  • Patients with any form of clinical atherosclerotic CVD

  • Patients with primary LDL-C levels of 190 mg/dL or greater

  • Patients aged 40-75 years with diabetes and LDL-C levels of 70-189 mg/dL

  • Patients aged 40-75 years without diabetes and with an estimated 10-year atherosclerotic CVD risk of 7.5% or higher

In patients with LDL-C levels of 190 or higher, high-intensity statins are indicated to achieve at least a 50% reduction in LDL-C. The guidelines do not indicate specific LDL-C or non–high-density lipoprotein cholesterol (HDL-C) target levels. However, many clinicians use target levels of less than 70 mg/dL for secondary prevention and less than 100 mg/dL for primary prevention.

For more on CVD risk factors, read here.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.